Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07715136 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This single-arm, open-label, phase I trial evaluates the safety and tolerability of ICG318 CAR-T (BCMA-CD19-IL-15/IL15sushi cCAR T cells) in patients with refractory Idiopathic inflammatory myopathy (IIM).
Trial Details
NCT Number NCT07715136
Lead Sponsor iCell Gene Therapeutics
Conditions
(from sponsor)		 Inflammatory Myopathy
Related terms Antisynthetase syndrome, Dermatomyositis, Myositis, Polymyositis
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov